HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ErbB-3 Receptor

A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF RECEPTOR and the ERBB-2 RECEPTOR. Overexpression of the erbB-3 receptor is associated with TUMORIGENESIS.
Also Known As:
Receptor, ErbB-3; Proto-Oncogene Protein c-erbB-3; Proto-Oncogene Proteins erbB-3; Proto-oncogene-like Protein c-ErbB-2; Tyrosine Kinase-type Cell Surface Receptor HER3; HER 3 Proto Oncogene Protein; Protein c-ErbB-2, Proto-oncogene-like; Proto Oncogene Protein c erbB 3; Proto Oncogene Protein erbB 3; Proto Oncogene Proteins erbB 3; Proto oncogene like Protein c ErbB 2; Proto-Oncogene Protein, HER-3; Receptor, ErbB 3; Tyrosine Kinase type Cell Surface Receptor HER3; c erbB 3 Protein; c-ErbB-2, Proto-oncogene-like Protein; c-erbB-3, Proto-Oncogene Protein; erbB 3 Protein; erbB-3, Proto-Oncogene Protein; erbB-3, Proto-Oncogene Proteins; HER-3 Proto-Oncogene Protein; Proto-Oncogene Protein erbB-3; c-erbB-3 Protein; erbB-3 Protein
Networked: 16 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Backs, Johannes: 1 article (03/2013)
2. Bauer, Andrea: 1 article (03/2013)
3. Dösch, Andreas: 1 article (03/2013)
4. Ehlermann, Philipp: 1 article (03/2013)
5. Fischer, Simon: 1 article (03/2013)
6. Franke, Jennifer: 1 article (03/2013)
7. Frese, Karen S: 1 article (03/2013)
8. Haas, Jan: 1 article (03/2013)
9. Hardt, Stefan: 1 article (03/2013)
10. Hassel, Sarah: 1 article (03/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Adenocarcinoma
4. Breast Neoplasms (Breast Cancer)
5. Chronic Pancreatitis

Related Drugs and Biologics

1. Integrin alpha6beta4
2. Neuregulins
3. Proliferating Cell Nuclear Antigen (PCNA)
4. Purinergic P1 Receptors (Adenosine Receptor)
5. Oncogene Proteins (Oncogene Protein)
6. Tyrosine (L-Tyrosine)
7. Proteins (Proteins, Gene)
8. Phosphotransferases (Kinase)
9. Paraffin
10. Ligands